等待开盘 03-26 09:30:00 美东时间
-0.030
-0.12%
Protiviti and BoardProspects to host global webinar on board-level AI oversight survey Protiviti and BoardProspects said they will host a global webinar in March 2026 to discuss findings from their Global Board Governance Survey on board oversight of AI. The survey report referenced in the release i
03-18 17:58
MENLO PARK, Calif., March 10, 2026 /PRNewswire/ -- Protiviti, a global consulting firm, today announced the winners of its second annual Audit Innovator Award, recognizing internal audit lea...
03-10 23:58
今日重点评级关注:HC Wainwright & Co.:维持BridgeBio Oncology"买入"评级,目标价从27美元升至29美元;韦德布什:维持WAVE Life Sciences"跑赢大市"评级,目标价从33美元升至35美元
03-09 11:47
Protiviti, a global consulting firm and recognized leader in internal audit, risk management, and technology consulting, today announced a strategic alliance with Fieldguide, a leader in agentic AI for professional
03-03 22:30
Protiviti Partners With Fieldguide to Accelerate AI-Enabled Internal Audit and SOX Transformation Protiviti, a consulting firm under Robert Half Inc., announced a strategic alliance with Fieldguide to integrate Fieldguide’s agentic AI and workflow automation into Protiviti’s global internal audit se
03-03 22:26
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从12.5美元升至13美元;Lake Street:维持Insight Molecular"买入"评级,目标价从8美元升至12美元
02-18 16:48
MENLO PARK, Calif., Feb. 12, 2026 /PRNewswire/ -- Robert Half Inc. (NYSE: RHI) today announced that its board of directors has approved a quarterly cash dividend of $0.59 per share on the co...
02-13 05:25
Robert Half Appoints Ryan Skubis as Senior District President for Business Operations Modernization Robert Half Inc. has appointed Ryan Skubis as senior district president, business operations modernization. In this newly created role, Skubis will lead efforts to enhance the company's operational in
02-13 00:15
今日重点评级关注:Canaccord Genuity:维持Wave Life Sciences Ltd."买入"评级,目标价从40美元升至43美元;花旗:维持Palantir Technologies"买入"评级,目标价从235美元升至260美元
02-04 12:15
今日重点评级关注:Benchmark:维持Charter Communications"买入"评级,目标价从425美元升至455美元;BTIG:维持LifeStance Health Gr"买入"评级,目标价从10美元升至11美元
02-03 09:06